Crystal Mead
Physician Assistant · Edgewater, FLNPI 1497861306
Payments from drug & device makers
Across 164 payments — averaging $21.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$619
- Insulet Corporation$555
- Novo Nordisk$518
- Penumbra, Inc.$263
- AbbVie$192
- Dexcom, Inc.$156
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,488100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 34 | $619 |
| Insulet Corporation | 20 | $555 |
| Novo Nordisk | 28 | $518 |
| Penumbra, Inc. | 2 | $263 |
| AbbVie | 13 | $192 |
| Dexcom, Inc. | 7 | $156 |
| Bayer | 6 | $123 |
| BETA Bionics, Inc. | 5 | $117 |
| Radius Health, Inc. | 4 | $99 |
| Lilly USA, LLC | 5 | $95 |
| Corcept Therapeutics | 4 | $77 |
| Amneal Pharmaceuticals LLC | 5 | $76 |
| Tandem Diabetes Care, Inc. | 3 | $71 |
| Amgen | 3 | $64 |
| Merck | 3 | $54 |
| Tolmar, Inc. | 3 | $52 |
| Alvogen Inc | 3 | $51 |
| Boehringer Ingelheim | 3 | $48 |
| Astellas Pharma US Inc | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Novartis | 2 | $34 |
| AstraZeneca | 1 | $33 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Ascensia Diabetes Care US Inc. | 1 | $20 |
| Recordati_rare_diseases_inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $19 |
| Clarus Therapeutics Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$263
- Omnipod$233
- RYBELSUS$102
How this compares
$3,488 in reported general payments places this provider in the 85th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 193 | $280,719 |
| JardianceEmpagliflozin | 124 | $142,200 |
| MounjaroTirzepatide | 94 | $137,854 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 43 | $57,765 |
| Tresiba Flextouch U-200Insulin Degludec | 33 | $50,297 |
| TrulicityDulaglutide | 27 | $49,211 |
| FarxigaDapagliflozin Propanediol | 42 | $46,668 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $43,542 |
| RybelsusSemaglutide | 17 | $36,756 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $23,771 |
| JanuviaSitagliptin Phosphate | 25 | $17,544 |
| SynthroidLevothyroxine Sodium | 119 | $11,784 |
| Levothyroxine Sodium | 433 | $5,744 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $3,553 |
| Rosuvastatin Calcium | 78 | $2,057 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $518 | $317,475210 claims |
| Lilly USA, LLCMounjaro, Trulicity | $95 | $187,065121 claims |
| Boehringer IngelheimJardiance | $48 | $142,200124 claims |
| AstraZenecaFarxiga | $33 | $46,66842 claims |
| MerckJanuvia | $54 | $17,54425 claims |
| AbbVieSynthroid | $192 | $11,784119 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $76 | $6,022453 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Edgewater
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.